Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine

Animal models of respiratory syncytial virus infection

(2017) Geraldine Taylor   VACCINE

Progress toward a Respiratory Syncytial Virus Vaccine

(2016) Kathleen M. Neuzil   Clinical and Vaccine Immunology

A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats

(2016) Christina A. Rostad et al.   JOURNAL OF VIROLOGY

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

(2016) Christopher C. Stobart et al.   Nature Communications

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

(2015) Maximillian S. Habibi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels

(2015) Marloes Vissers et al.   Clinical and Vaccine Immunology

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells

(2015) Tatiana Chirkova et al.   JOURNAL OF GENERAL VIROLOGY

A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children

(2015) Ruth A. Karron et al.   Science Translational Medicine

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures

(2015) Sara M. Johnson et al.   PLoS Pathogens

CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner

(2015) Kwang-Il Jeong et al.   PLoS One

Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis

(2013) Harish Nair et al.   LANCET

Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys

(2010) Anne Schaap-Nutt et al.   VACCINE

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE